PAOG Previews Next Acquisition Anticipated In Conjunction With CRO Partnership And CTAP Application
01 August 2020 - 3:16AM
InvestorsHub NewsWire
Sandusky, OH -- July 31, 2020 --
InvestorsHub NewsWire -- PAO Group, Inc. (USOTC:
PAOG) today previewed its next acquisition after just this week
closing the acquisition of a cannabis biopharmaceutical asset to
treat Chronic Obstructive Pulmonary Disease (COPD) and a cannabis
cultivation operation developing a proprietary cannabis
cultivar.
The COPD treatment, RespRx, is derived
from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled “METHOD AND
APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE
CANNABIS PLANT.”
PAOG anticipates soon entering into a
Contract Research Organization (CRO) agreement in
conjunction with advancing an Investigational New Drug Application
(IND) to ultimately achieve Food and Drug
Administration (FDA) approval for RespRx as a
COPD treatment.
Based on
positive results from an informal trial of RexpRX with 25 COVID-19
patients, PAOG also plans to make Coronavirus Treatment
Acceleration Program (CTAP)
application after entering into a CRO agreement.
PAOG has a
working agreement to close the acquisition of the underlying
extraction patent in conjunction with executing the CRO
agreement. The CRO agreement and corresponding acquisition
are anticipated to close by the end of
August.
CEO James C.
DiPrima discusses the PAOG CRO, IND and CTAP developments in
his interview on MoneyTV with Donald Baillargeon released
today.
MoneyTV with
Donald Baillargeon is the internationally syndicated television
program all about money and what makes it happen, featuring
informative interviews with company CEOs and executives, providing
insights into their operations and outlooks for their futures.
MoneyTV is seen in over 200 million TV households in more than 75
countries.
The MoneyTV
Interview is available at www.moneytv.net and will be syndicated across multiple channels
and platforms.
Forward-Looking
Statements: Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933 and Rule 3b-6 under the Securities
Exchange Act of 1934, and are subject to the safe harbor created by
those rules. All statements, other than statements of fact,
included in this release, including, without limitation, statements
regarding potential future plans and objectives of the company are
forward-looking statements that involve risks and uncertainties.
There can be no assurance that such statements will prove to be
accurate and actual results and future events could differ
materially from those anticipated in such statements. Technical
complications, which may arise, could prevent the prompt
implementation of any strategically significant plan(s) outlined
above. The Company undertakes no duty to revise or update any
forward-looking statements to reflect events or circumstances after
the date of this release.
CONTACT
INFORMATION
Contact Us:
Jim DiPrima
888-272-6472
info@pao.group
PAO (PK) (USOTC:PAOG)
Historical Stock Chart
From Apr 2024 to May 2024
PAO (PK) (USOTC:PAOG)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about PAO Group Inc (PK) (OTCMarkets): 0 recent articles
More PAO Group Inc (PK) News Articles